Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Melcher

Showing results (111-120 of 134) with videos related to

Pageof 14
Sort By:
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 25, 2009
Clinical grade OK432-activated dendritic cells: in vitro characterization and tracking during intralymphatic deliveryEmma West, Ruth Morgan, Karen Scott, et al.
Journal for Immunotherapy of Cancer|September 26, 2025
Addition of oncolytic virotherapy to clinical isolated limb perfusion for melanoma and sarcoma activates antitumor immunityAndrew J Hayes, Emma J Davies, Michelle Wilkinson, et al.
Journal for Immunotherapy of Cancer|March 20, 2021
Reovirus-induced cell-mediated immunity for the treatment of multiple myeloma within the resistant bone marrow nicheLouise M E Müller, Gemma Migneco, Gina B Scott, et al.
Journal for Immunotherapy of Cancer|July 26, 2024
Combination of oncolytic Maraba virus with immune checkpoint blockade overcomes therapy resistance in an immunologically cold model of advanced melanoma with dysfunctional T-cell receptor signallingEdward Armstrong, Matthew K L Chiu, Shane Foo, et al.
Nature Communications|June 27, 2024
Expression of tumor antigens within an oncolytic virus enhances the anti-tumor T cell responseMason J Webb, Thanich Sangsuwannukul, Jacob van Vloten, et al.
Science Translational Medicine|April 13, 2022
Oncolytic virus-mediated expansion of dual-specific CAR T cells improves efficacy against solid tumors in miceLaura Evgin, Tim Kottke, Jason Tonne, et al.
Clinical and Translational Radiation Oncology|October 14, 2022
PEARLS - A multicentre phase II/III trial of extended field radiotherapy for androgen sensitive prostate cancer patients with PSMA-avid pelvic and/or para-aortic lymph nodes at presentationJulia Murray, Clare Cruickshank, Thomas Bird, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 26, 2022
Dynamic Changes in the NK-, Neutrophil-, and B-cell Immunophenotypes Relevant in High Metastatic Risk Post Neoadjuvant Chemotherapy-Resistant Early Breast CancersPatrycja Gazinska, Charlotte Milton, Jacopo Iacovacci, et al.
Journal for Immunotherapy of Cancer|March 8, 2021
Differential and longitudinal immune gene patterns associated with reprogrammed microenvironment and viral mimicry in response to neoadjuvant radiotherapy in rectal cancerAnna Wilkins, Elisa Fontana, Gift Nyamundanda, et al.
Gut|September 5, 2020
Immune landscape, evolution, hypoxia-mediated viral mimicry pathways and therapeutic potential in molecular subtypes of pancreatic neuroendocrine tumoursKate Young, Rita T Lawlor, Chanthirika Ragulan, et al.
Pageof 14

Showing results (111-120 of 134) with videos related to

Sort By:
Pageof 14
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 25, 2009
Clinical grade OK432-activated dendritic cells: in vitro characterization and tracking during intralymphatic deliveryEmma West, Ruth Morgan, Karen Scott, et al.
Journal for Immunotherapy of Cancer|September 26, 2025
Addition of oncolytic virotherapy to clinical isolated limb perfusion for melanoma and sarcoma activates antitumor immunityAndrew J Hayes, Emma J Davies, Michelle Wilkinson, et al.
Journal for Immunotherapy of Cancer|March 20, 2021
Reovirus-induced cell-mediated immunity for the treatment of multiple myeloma within the resistant bone marrow nicheLouise M E Müller, Gemma Migneco, Gina B Scott, et al.
Journal for Immunotherapy of Cancer|July 26, 2024
Combination of oncolytic Maraba virus with immune checkpoint blockade overcomes therapy resistance in an immunologically cold model of advanced melanoma with dysfunctional T-cell receptor signallingEdward Armstrong, Matthew K L Chiu, Shane Foo, et al.
Nature Communications|June 27, 2024
Expression of tumor antigens within an oncolytic virus enhances the anti-tumor T cell responseMason J Webb, Thanich Sangsuwannukul, Jacob van Vloten, et al.
Science Translational Medicine|April 13, 2022
Oncolytic virus-mediated expansion of dual-specific CAR T cells improves efficacy against solid tumors in miceLaura Evgin, Tim Kottke, Jason Tonne, et al.
Clinical and Translational Radiation Oncology|October 14, 2022
PEARLS - A multicentre phase II/III trial of extended field radiotherapy for androgen sensitive prostate cancer patients with PSMA-avid pelvic and/or para-aortic lymph nodes at presentationJulia Murray, Clare Cruickshank, Thomas Bird, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 26, 2022
Dynamic Changes in the NK-, Neutrophil-, and B-cell Immunophenotypes Relevant in High Metastatic Risk Post Neoadjuvant Chemotherapy-Resistant Early Breast CancersPatrycja Gazinska, Charlotte Milton, Jacopo Iacovacci, et al.
Journal for Immunotherapy of Cancer|March 8, 2021
Differential and longitudinal immune gene patterns associated with reprogrammed microenvironment and viral mimicry in response to neoadjuvant radiotherapy in rectal cancerAnna Wilkins, Elisa Fontana, Gift Nyamundanda, et al.
Gut|September 5, 2020
Immune landscape, evolution, hypoxia-mediated viral mimicry pathways and therapeutic potential in molecular subtypes of pancreatic neuroendocrine tumoursKate Young, Rita T Lawlor, Chanthirika Ragulan, et al.
Pageof 14